These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30521092)

  • 1. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
    Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
    Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
    Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
    Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
    Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
    Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
    Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States.
    Stenmark MH; Shumway D; Guo C; Vainshtein J; Mierzwa M; Jagsi R; Griggs JJ; Banerjee M
    Laryngoscope; 2017 Oct; 127(10):2270-2278. PubMed ID: 28304083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
    Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
    Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
    Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
    Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic and Racial Disparities and Survival of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Rotsides JM; Oliver JR; Moses LE; Tam M; Li Z; Schreiber D; Jacobson AS; Hu KS; Givi B
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):131-138. PubMed ID: 32660368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus-induced oropharyngeal cancer in Hispanics in the United States.
    Thomas GR; Lo K; Nwojo R
    Laryngoscope; 2017 May; 127(5):1097-1101. PubMed ID: 27891616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.